Search Results - "Hampton, K K"

Bedside Ultrasonography in Clinical Education and Practice Survey: Evaluation of a Pilot Educational Intervention for Medical Students by Hampton, K

Get full text

Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice by Smith, Clare M, Baker, Richard E, Proulx, Megan K, Mishra, Bibhuti B, Long, Jarukit E, Park, Sae Woong, Lee, Ha-Na, Kiritsy, Michael C, Bellerose, Michelle M, Olive, Andrew J, Murphy, Kenan C, Papavinasasundaram, Kadamba, Boehm, Frederick J, Reames, Charlotte J, Meade, Rachel K, Hampton, Brea K, Linnertz, Colton L, Shaw, Ginger D, Hock, Pablo, Bell, Timothy A, Ehrt, Sabine, Schnappinger, Dirk, Pardo-Manuel de Villena, Fernando, Ferris, Martin T, Ioerger, Thomas R, Sassetti, Christopher M

“…The outcome of an encounter with ( ) depends on the pathogen's ability to adapt to the variable immune pressures exerted by the host. Understanding this…”
Get full text

Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination by Adams, Lily E., Leist, Sarah R., Dinnon, Kenneth H., West, Ande, Gully, Kendra L., Anderson, Elizabeth J., Loome, Jennifer F., Madden, Emily A., Powers, John M., Schäfer, Alexandra, Sarkar, Sanjay, Castillo, Izabella N., Maron, Jenny S., McNamara, Ryan P., Bertera, Harry L., Zweigart, Mark R., Higgins, Jaclyn S., Hampton, Brea K., Premkumar, Lakshmanane, Alter, Galit, Montgomery, Stephanie A., Baxter, Victoria K., Heise, Mark T., Baric, Ralph S.

“…Group 2B β-coronaviruses (sarbecoviruses) have caused regional and global epidemics in modern history. Here, we evaluate the mechanisms of cross-sarbecovirus…”
Get full text

Chronic low back pain comorbidity count and its impact on exacerbating opioid and non‐opioid prescribing behavior by Moses‐Hampton, Malcolm K., Povieng, Boss, Ghorayeb, Joe H., Zhang, Yanyu, Wu, Hong

“…Research Objectives The objective of the study was to determine the characteristics of chronic low back pain (CLBP) comorbidity and its impact on opioid and…”
Get full text

Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans by Schäfer, Alexandra, Gralinski, Lisa E., Leist, Sarah R., Hampton, Brea K., Mooney, Michael A., Jensen, Kara L., Graham, Rachel L., Agnihothram, Sudhakar, Jeng, Sophia, Chamberlin, Steven, Bell, Timothy A., Scobey, D. Trevor, Linnertz, Colton L., VanBlargan, Laura A., Thackray, Larissa B., Hock, Pablo, Miller, Darla R., Shaw, Ginger D., Diamond, Michael S., de Villena, Fernando Pardo Manuel, McWeeney, Shannon K., Heise, Mark T., Menachery, Vineet D., Ferris, Martin T., Baric, Ralph S.

“…•First, we introduce and describe the feasibility of the CC as a screening platform for complex genetic regulation of SARS-Like group 2B coronaviruses…”
Get full text

Perianesthetic mortality in English Bulldogs: a retrospective analysis in 2010 - 2017 by Oda, Ayako, Wang, Wen Hui, Hampton, Amanda K, Robertson, James B, Posner, Lysa P

“…Many veterinarians consider English Bulldogs to have a greater perianesthetic mortality risk. The aims of this study were to 1) determine total and…”
Get full text

Forward genetic screen of homeostatic antibody levels in the Collaborative Cross identifies MBD1 as a novel regulator of B cell homeostasis by Hampton, Brea K, Plante, Kenneth S, Whitmore, Alan C, Linnertz, Colton L, Madden, Emily A, Noll, Kelsey E, Boyson, Samuel P, Parotti, Breantie, Xenakis, James G, Bell, Timothy A, Hock, Pablo, Shaw, Ginger D, de Villena, Fernando Pardo-Manuel, Ferris, Martin T, Heise, Mark T

“…Variation in immune homeostasis, the state in which the immune system is maintained in the absence of stimulation, is highly variable across populations. This…”
Get full text

Complex Genetic Architecture Underlies Regulation of Influenza-A-Virus-Specific Antibody Responses in the Collaborative Cross by Noll, Kelsey E., Whitmore, Alan C., West, Ande, McCarthy, Mary K., Morrison, Clayton R., Plante, Kenneth S., Hampton, Brea K., Kollmus, Heike, Pilzner, Carolin, Leist, Sarah R., Gralinski, Lisa E., Menachery, Vineet D., Schäfer, Alexandra, Miller, Darla, Shaw, Ginger, Mooney, Michael, McWeeney, Shannon, Pardo-Manuel de Villena, Fernando, Schughart, Klaus, Morrison, Thomas E., Baric, Ralph S., Ferris, Martin T., Heise, Mark T.

“…Host genetic factors play a fundamental role in regulating humoral immunity to viral infection, including influenza A virus (IAV). Here, we utilize the…”
Get full text

panmictic fiddler crab from the coast of Brazil? Impact of divergent ocean currents and larval dispersal potential on genetic and morphological variation in Uca maracoani by Wieman, A. C, Berendzen, P. B, Hampton, K. R, Jang, J, Hopkins, M. J, Jurgenson, J, McNamara, J. C, Thurman, C. L

“…Marine species tend to exhibit relatively less population structuring than terrestrial species owing to fewer barriers to gene flow and increased connectivity…”
Get full text

Modeling Temperature Regime and Physical Habitat Impacts from Restored Streamflow by Bair, Russell T., Tobin, Benjamin W., Healy, Brian D., Spangenberg, Claire E., Childres, Hampton K., Schenk, Edward R.

“…Water infrastructure updates at Grand Canyon National Park (GRCA) provide an opportunity to restore natural flow to Bright Angel Creek, adding an additional…”
Get full text

First report on the safety and efficacy of an extended half‐life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A by Hampton, K., Chowdary, P., Dunkley, S., Ehrenforth, S., Jacobsen, L., Neff, A., Santagostino, E., Sathar, J., Takedani, H., Takemoto, C. M., Négrier, C.

“…Background N8‐GP (turoctocog alfa pegol) is an extended half‐life glycoPEGylated recombinant factor VIII (FVIII) product developed for the prevention and…”
Get full text

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety by Lissitchkov, T., Hampton, K., von Depka, M., Hay, C., Rangarajan, S., Tuddenham, E., Holstein, K., Huth-Kühne, A., Pabinger, I., Knaub, S., Bichler, J., Oldenburg, J.

“…Introduction Nuwiq® [human cell line‐derived recombinant factor VIII (human‐cl rhFVIII)] is a new generation rFVIII protein, without chemical modification or…”
Get full text

Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction by CROFT, S. A, SAMANI, N. J, TEARE, M. D, HAMPTON, K. K, STEEDS, R. P, CHANNER, K. S, DALY, M. E

“…Glycoprotein (GP) VI plays a crucial role in platelet activation and aggregation. We investigated whether polymorphic variation at the GP VI locus confers an…”
Get full text

Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents by Frazier, H. N., Anderson, K. L., Maimaiti, S., Ghoweri, A. O., Kraner, S. D., Popa, G. J., Hampton, K. K., Mendenhall, M. D., Norris, C. M., Craven, R. J., Thibault, O.

“…Memory and cognitive decline are the product of numerous physiological changes within the aging brain. Multiple theories have focused on the oxidative,…”
Get full text

The impact of Xpert® MTB/RIF in sparsely populated rural settings by Van Den Handel, T., Hampton, K. H., Sanne, I., Stevens, W., Crous, R., Van Rie, A.

“…BACKGROUND: The impact of implementing Xpert® MTB/RIF and the choice of instrument placement on patient care in sparsely populated areas with poor access to…”
Get full text

Pathways driving the endocytosis of mutant and wild-type EGFR in cancer by Hampton, Kaia K, Craven, Rolf J

“…EGFR (epidermal growth factor receptor) is activated through changes in expression or mutations in a number of tumors and is a driving force in cancer…”
Get full text

TREATMENT BURDEN AND PATIENT PREFERENCE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY by K Hampton, P Knoebl, J Odgaard-Jensen, O Stasyshyn, JJT Zaw, JS Neergaard, B Zulfikar, GG Fabbron

“…Introduction: Concizumab is a humanised, recombinant monoclonal antibody administered to patients with haemophilia A/B with inhibitors (HAwI/HBwI) as a…”
Get full text

Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures by Zozulya, N., Kessler, C. M., Klukowska, A., Depka, M., Hampton, K., Hay, C. R. M., Jansen, M., Bichler, J., Knaub, S., Rangarajan, S.

“…Introduction Haemophilia A patients are at a high risk of excess bleeding during surgeries. The aim of haemostatic therapy during the perioperative period is…”
Get full text

Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population by Cruz Cisneros, Marta C, Anderson, Elizabeth J, Hampton, Brea K, Parotti, Breantié, Sarkar, Sanjay, Taft-Benz, Sharon, Bell, Timothy A, Blanchard, Matthew, Dillard, Jacob A, Dinnon, 3rd, Kenneth H, Hock, Pablo, Leist, Sarah R, Madden, Emily A, Shaw, Ginger D, West, Ande, Baric, Ralph S, Baxter, Victoria K, Pardo-Manuel de Villena, Fernando, Heise, Mark T, Ferris, Martin T

“…The COVID-19 pandemic led to the rapid and worldwide development of highly effective vaccines against SARS-CoV-2. However, there is significant…”
Get full text

Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programme by Oldenburg, J., Windyga, J., Hampton, K., Lalezari, S., Tseneklidou-Stoeter, D., Beckmann, H., Maas Enriquez, M.

“…Introduction BAY 81‐8973 is a recombinant factor VIII (rFVIII) with the same amino acid sequence as Bayer's sucrose‐formulated rFVIII (rFVIII‐FS) but…”
Get full text